Evolent Health Inc (NYSE:EVH) price on Thursday, February 27, fall -8.15% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $8.68.
A look at the stock’s price movement, the close in the last trading session was $9.45. Turning to its 52-week performance, $35.00 and $9.40 were the 52-week high and 52-week low respectively. Overall, EVH moved -16.70% over the past month.
Evolent Health Inc’s market cap currently stands at around $1.01 billion, with investors looking forward to this quarter’s earnings report slated for in March.
Analysts have a consensus estimate of 460.11M for the company’s revenue for the quarter, with a low and high estimate of 454.22M and 466.96M respectively. The average forecast suggests down to a -28.07% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 2.09B, representing a -18.25% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that EVH is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
5 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 5 recommend EVH as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
EVH’s current price about -13.82% and -18.55% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 31.56, while 7-day volatility ratio is 8.19% and 5.47% in the 30-day chart. Further, Evolent Health Inc (EVH) has a beta value of 1.49, and an average true range (ATR) of 0.62. Analysts have given the company’s stock an average 52-week price target of $19, forecast between a low of $14 and high of $38. Looking at the price targets, the low is -61.29% off current price level while to achieve the yearly target high, price needs to move -337.79%. Nonetheless, investors will most likely welcome a -118.89% jump to $19 which is the analysts’ median price.
If we refocus on Evolent Health Inc (NYSE:EVH), historical trading data shows that trading volumes averaged 2.30 million over the past 3 months. The company’s latest data on shares outstanding shows there are 115.04 million shares.
The 1.82% of Evolent Health Inc’s shares are in the hands of company insiders while institutional holders own 107.18% of the company’s shares. Current price change has pushed the stock -22.84% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the EVH stock continues to rise going into the next quarter.
